Ashwagandha for women: hormones, menopause and open questions

“For hormone balance” sounds like a clear goal, but medically it is vague. Perimenopausal symptoms, an irregular cycle and trouble getting pregnant are different questions. The fact that some studies measure hormone levels does not make ashwagandha a single answer to all of them.

A study in perimenopause

In a randomized, double-blind study from 2021, 100 women with perimenopausal symptoms were assigned to a root extract or placebo. The study tested 300 mg twice a day for eight weeks; 91 participants completed it. The extract group showed more favorable changes on symptom and quality-of-life scales. Estradiol rose and FSH and LH fell compared with placebo; for testosterone, no significant difference between the groups was found. Gopal et al., primary study.

The result concerns one specific stage of life and one specific product. It does not show that ashwagandha “normalizes” hormones in all women. The short duration and limited number of participants also rule out any broad conclusion about longer-term safety.

Symptoms and lab values are different endpoints

For a woman with symptoms, what usually matters most is whether they ease and daily life gets easier. A changed lab value can contribute to scientific research, but it does not automatically answer that question.

The direction of a change is not enough either: with a hormone, “more” is not inherently better and “less” is not inherently worse. How to read it depends on the specific situation and the question being asked. A blanket goal of pushing as many values as possible in one direction cannot be derived from the study.

The abstract reports statistical differences, but for the scales discussed here it does not provide all the details needed to judge the clinical size of the effect independently. That is why the result is described as a signal, not as a benefit every user can count on noticing.

What the study did not examine

The study shows neither a treatment for PCOS, nor higher pregnancy rates, nor general cycle regulation in younger women. That would require studies in those specific groups with suitable outcome measures.

Nor did it test individually adjusting the dose based on repeated progesterone measurements. The fact that researchers measure hormones does not lead to a general recommendation for a commercial hormone panel before and after taking a supplement.

No self-treatment program can be derived from these open research questions. Otherwise, a broad term like “balance” ends up hiding which specific benefit was actually studied.

Pregnancy and breastfeeding

The BfR (the German Federal Institute for Risk Assessment) advises pregnant and breastfeeding women to avoid ashwagandha products. A product marketed for fertility or women’s well-being is not automatically suitable for these stages of life. The other risk groups and interactions are covered in the safety overview.

If you are trying to conceive, it makes sense to discuss taking it with the professional caring for you. What counts is your personal situation and the limits of the available data. Calling a product “natural” does not answer these questions.

The right question for a consultation

Instead of looking for hormonal optimization in general, the goal can be put in concrete terms: what symptoms do you have, how much do they affect daily life and since when? What treatments or products are you already using?

A description like this helps define the relevant question. The study discussed here can contribute to that assessment. It is, however, no substitute for an individual medical evaluation and no evidence for swapping established treatment options for just any ashwagandha product.